These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20665136)

  • 1. Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?
    Danila MI; Hughes LB; Brown EE; Morgan SL; Baggott JE; Arnett DK; Bridges SL
    Curr Rheumatol Rep; 2010 Oct; 12(5):342-7. PubMed ID: 20665136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
    den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
    J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
    Hobl EL; Jilma B; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Rizovski B; Mader RM
    Clin Exp Rheumatol; 2012; 30(2):156-63. PubMed ID: 22152098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells.
    Korell J; Stamp LK; Barclay ML; Dalrymple JM; Drake J; Zhang M; Duffull SB
    Clin Pharmacokinet; 2013 Jun; 52(6):475-85. PubMed ID: 23483363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry.
    Meesters RJ; den Boer E; de Jonge R; Lindemans J; Luider TM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3063-70. PubMed ID: 21953961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis.
    Pan S; Stamp LK; Duffull SB; Barclay ML; Dalrymple JM; Drake J; Zhang M; Korell J
    Clin Pharmacokinet; 2014 Dec; 53(12):1161-70. PubMed ID: 25204405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
    Angelis-Stoforidis P; Vajda FJ; Christophidis N
    Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
    Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
    Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
    Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
    Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis.
    Mo X; Wen Y; Ren B; Chen J; Xu C; Wang X; Huang M; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():41-8. PubMed ID: 22999476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.
    Goss SL; Klein CE; Jin Z; Locke CS; Rodila RC; Kupper H; Burmester GR; Awni WM
    Clin Ther; 2018 Feb; 40(2):309-319. PubMed ID: 29402521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
    Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
    Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
    Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis.
    de Rotte MC; de Jong PH; den Boer E; Pluijm SM; Özcan B; Weel AE; Lindemans J; Hazes JM; de Jonge R
    Arthritis Rheumatol; 2014 Aug; 66(8):2026-36. PubMed ID: 24692301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Dervieux T; Orentas Lein D; Marcelletti J; Pischel K; Smith K; Walsh M; Richerson R
    Clin Chem; 2003 Oct; 49(10):1632-41. PubMed ID: 14500588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis.
    Stamp LK; Barclay ML; O'Donnell JL; Zhang M; Drake J; Frampton C; Chapman PT
    J Rheumatol; 2011 Dec; 38(12):2540-7. PubMed ID: 21965639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis.
    Dervieux T; Zablocki R; Kremer J
    Rheumatology (Oxford); 2010 Dec; 49(12):2337-45. PubMed ID: 20713496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte methotrexate-polyglutamate assay using fluorescence polarization immunoassay technique: application to the monitoring of patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Aug; 129(8):1001-5. PubMed ID: 19652507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
    Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
    Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.